System consolidation: how scale becomes leverage

If the hospital walks away, Aetna's network still has three other hospitals in the metro area. The employer barely notices. The hospital, meanwhile, loses a big chunk of insured patients overnight. The insurer holds the leverage.

Now the hospital's negotiating range is narrow. It cannot push rates far above cost, because it is replaceable.

What changes when systems combine

Merge that hospital with the other three in the metro. Now there is one system controlling most inpatient beds in the region.

The math for the insurer inverts. If the system walks, Aetna cannot build a credible network. Employers will not buy insurance that excludes the region's dominant hospitals, especially the ones with the only trauma center, NICU (neonatal intensive care unit), or transplant program. The insurer becomes the replaceable party.

This is called a "must-have" system. Once a hospital group is must-have, it can demand higher rates, and the insurer largely has to pay, because passing on the deal means losing employer clients.

The all-or-nothing lever

Consolidation unlocks a specific tactic: bundling contracts across all facilities. The Sutter case showed the playbook. A system with one prestige academic hospital and several ordinary community hospitals says: to get the prestige hospital in your network, you must take all of them, at rates we set.

The insurer needs the crown-jewel hospital. To get it, they overpay for the rest. That is how scale converts one strong asset into system-wide pricing power.

Where the 10 to 20 percent comes from

The often-cited estimate is that mergers raise prices by roughly 10 to 20 percent, and higher (sometimes 40 percent plus) when the merging hospitals were close local competitors. These figures come from health economics research; a good, readable summary of the evidence is the Nicholas Bloom and Zack Cooper work via the Health Care Pricing Project. Treat these as academic estimates, not guarantees.

Here is a simplified worked example. Numbers are illustrative, not real contract data.

• Hospital A does 10,000 commercial admissions a year at an average negotiated rate of $18,000 per admission.
• Baseline commercial revenue: 10,000 x $18,000 = $180 million.
• After merging into a must-have system, it renegotiates a 15 percent rate increase.
• New rate: $18,000 x 1.15 = $20,700 per admission.
• New commercial revenue: 10,000 x $20,700 = $207 million.
• Gain from pricing power alone: $27 million per year, with zero change in the care delivered.

That last point is what regulators worry about. The extra $27 million is not from better outcomes or lower costs. It is pure negotiating leverage, and it flows to premiums that employers and workers ultimately pay.

Who absorbs the cost

Follow the money down the chain.

1. System raises commercial rates.

2. Insurer pays more, then raises premiums to employers.

3. Employers pass costs to workers via higher premium contributions, higher deductibles, or lower wage growth.

The patient rarely sees the hospital price directly. That opacity is why the leverage is so durable: the people paying (workers) are far from the people negotiating (system and insurer).

Why regulators arrive late

Merger review in the US runs through two agencies: the Federal Trade Commission (FTC) and the Department of Justice (DOJ) Antitrust Division. They review deals under the Clayton Act (the antitrust law that bars mergers that "substantially lessen competition") using the Hart-Scott-Rodino (HSR) Act, which requires companies to notify regulators before large mergers close.

Three structural reasons they struggle:

Cross-market mergers slip through. Traditional review asks: do these two hospitals compete in the same local market? If System X buys hospitals in different cities, there is no obvious head-to-head overlap, yet the combined system still gains bundling leverage with statewide insurers. Regulators have only recently started challenging these.

Nonprofit status confuses the picture. Many large systems are nonprofit. Regulators and courts historically assumed nonprofits would not exploit market power. Evidence shows nonprofit systems raise prices too.

"Physician roll-ups" fly under the radar. Systems buy up independent doctor practices one at a time. Each deal is small enough to fall below the HSR reporting threshold (around $126.4 million for 2025, adjusted annually; confirm the current figure at the FTC's HSR thresholds page). Dozens of small deals add up to regional dominance no single filing ever flagged.

In 2023 the FTC and DOJ issued updated Merger Guidelines explicitly addressing serial acquisitions and cross-market effects, a sign the enforcers are trying to catch up. Whether courts follow is still being tested.

Europe: a different power balance

In much of Europe, the payer is the state. In England, the NHS (National Health Service) both funds and largely provides care, so there is no commercial rate negotiation of the US kind. In Germany and the Netherlands, insurers negotiate with hospitals, but within tighter regulated price frameworks. The result: hospital consolidation happens in Europe too, but the "raise commercial rates 15 percent" lever is far weaker because the state caps or steers prices. The pricing power story in this lesson is mostly a US phenomenon.

The counterpressure: insurers consolidate too

Payers are not passive. They merge and integrate to rebuild their own leverage.

The clearest move is vertical integration: insurers buying providers directly. UnitedHealth's Optum unit now employs or is affiliated with tens of thousands of physicians, making UnitedHealth one of the largest employers of doctors in the US. CVS Health owns Aetna and the provider group Oak Street Health.

When an insurer owns providers, it can steer patients to its own lower-cost sites and weaken a hospital system's must-have status. The power balance becomes an arms race: systems consolidate to raise rates, insurers integrate to resist and to capture margin themselves. The patient and employer sit in the middle, funding both sides.

How to read any hospital market

When you assess a regional hospital market, ask four questions:

1. Is any system "must-have"? Does it hold the only trauma center, the dominant brand, or most beds?

2. Can insurers build a network without it? If no, the system has pricing power.

3. Is consolidation happening below the radar? Watch physician roll-ups and cross-market deals.

4. How integrated are the payers? An Optum-style insurer changes the fight entirely.

Key Takeaways

• Consolidation raises prices mainly by making a system "must-have" so insurers cannot build a network without it, converting scale directly into commercial rate increases estimated at 10 to 20 percent.
• The lever is the commercial contract; Medicare and Medicaid rates are set by formula and cannot be bargained up, so all pricing power lives on the commercial side.
• Higher rates flow through insurers to employers to workers via premiums, deductibles, and suppressed wages, and the opacity keeps the leverage durable.
• US regulators (FTC, DOJ, under the Clayton and HSR Acts) arrive late because cross-market mergers, nonprofit status, and sub-threshold physician roll-ups evade traditional review.
• Insurers fight back through vertical integration (UnitedHealth/Optum, CVS/Aetna), turning the market into a scale-versus-scale arms race rather than a one-sided win for hospitals.